Resultados de la búsqueda 121-130 of 12460 for 3-day movement protocol
Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs ...
In this study additional heart rhythm measurements will be collected during the implant procedure to better understand how His bundle and/or parahisian pacing ( ...
Page 1. Page 2.
This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns of ...
... protocol, and to generate a large catalog and ... moving or using, and other complications in ... Ir a página 33 · Ir a página 44 · Ir a página 55 · Ir a ...
This randomized, active controlled, multicenter Phase III open-label study is designed to evaluate the efficacy and safety of alectinib compared with ...
The purpose of this study is to compare the 1-year cumulative incidence of severe GVHD (from day of HCT) defined as Grade III ... This protocol is being ...
Page 1.
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?